Titlebook: Nano Drug Delivery for Cancer Therapy; Principles and Pract Firdos Alam Khan Book 2023 The Editor(s) (if applicable) and The Author(s), und

法庭

書目名稱Nano Drug Delivery for Cancer Therapy影響因子(影響力)




書目名稱Nano Drug Delivery for Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Nano Drug Delivery for Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy被引頻次




書目名稱Nano Drug Delivery for Cancer Therapy被引頻次學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy年度引用




書目名稱Nano Drug Delivery for Cancer Therapy年度引用學(xué)科排名




書目名稱Nano Drug Delivery for Cancer Therapy讀者反饋




書目名稱Nano Drug Delivery for Cancer Therapy讀者反饋學(xué)科排名

Fracture

Book 2023 and lung cancer. It reviews the significance of nano drug delivery in cancer therapy, the application of nanoparticles in overcoming drug resistance, targeted therapy, and immunotherapy. The book also covers topics related to the synthesis of different types, shapes, and sizes of nanocarriers using

debase

conference

Firdos Alam KhanDiscusses applications of nano drug delivery.Explains the synthesis functionalized and conjugation nanocarriers.Elaborates on advantages and limitations of nanocarriers

Constitution

nonradioactive

Colonoscopy

種植,培養(yǎng)

Synthesis of Different Types, Shapes, and Sizes of Nanocarriers Using Synthetic and Biological Apprinal product’s characteristics such as size and morphology, selection of the proper method is critical. In general, the nanomaterial synthesis methods can be classified into two main categories: top-down and bottom-up. In the top-down methods, bulk materials are converted into nanomaterials using sp

Adj異類的

Synthesis of Nanocarriers Loaded with Anti-Cancer Drugs by Using Functionalization or Conjugations,ea, designable pore structures, and robust mechanical/chemical stability with adjustable optical and electrical properties. Inorganic nanoparticles are interesting as nanocarriers for drug delivery due to the chemical, mechanical strength, microbial resistance, and biocompatibility. The presence of

preservative

Nano-Drug Carriers for Chemotherapeutic Agents Delivery in Cancer Disease Treatment, well as therapeutic molecules for its treatment. However, innumerable chemotherapeutics that are experimentally evaluated are unable to reach bench to bedside due to many drawbacks. These include poor bioavailability, lower bioretention, and non-specific effects along with systemic toxicity. Additi